Tech Company Financing Transactions
Tikvah Therapeutics Funding Round
Private investors participated in a $10 million funding round for Tikvah Therapeutics. The funding round closed on 7/11/2007.
Transaction Overview
Company Name
Announced On
7/11/2007
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
75 Fifth Street NW 207
Atlanta, GA 30308
USA
Atlanta, GA 30308
USA
Phone
Website
Email Address
Overview
Tikvah Therapeutics, Inc. is a biopharmaceutical company that acquires, develops, and plans to commercialize, novel therapeutic products addressing significant unmet medical needs and disorders relating to the Central Nervous System (CNS) -- neurology and psychiatry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harold Shlevin
Browse more venture capital transactions:
Prev: 7/11/2007: VirtualLogix venture capital transaction
Next: 7/11/2007: 60Frames Entertainment venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs